Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Life Sci ; 295: 120391, 2022 Apr 15.
Article in English | MEDLINE | ID: mdl-35149116

ABSTRACT

The microorganism resistance to antibiotics has become one of the most worrying issues for science due to the difficulties related to clinical treatment and the rapid spread of diseases. Efflux pumps are classified into six groups of carrier proteins that are part of the different types of mechanisms that contribute to resistance in microorganisms, allowing their survival. The present study aimed to carry out a bibliographic review on the superfamilies of carriers in order to understand their compositions, expressions, substrates, and role in intrinsic resistance. At first, a search for manuscripts was carried out in the databases Medline, Pubmed, ScienceDirect, and Scielo, using as descriptors: efflux pump, expression, pump inhibitors and efflux superfamily. For article selection, two criteria were taken into account: for inclusion, those published between 2000 and 2020, including textbooks, and for exclusion, duplicates and academic collections. In this research, 139,615 published articles were obtained, with 312 selected articles and 7 book chapters that best met the aim. From the comprehensive analysis, it was possible to consider that the chromosomes and genetic elements can contain genes encoding efflux pumps and are responsible for multidrug resistance. Even though this is a well-explored topic in the scientific community, understanding the behavior of antibiotics as substrates that increase the expression of pump-encoding genes has challenged medicine. This review study succinctly summarizes the most relevant features of these systems, as well as their contribution to multidrug resistance.


Subject(s)
Carrier Proteins/physiology , Drug Resistance, Microbial/physiology , Membrane Transport Proteins/metabolism , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/genetics , Biological Transport , Carrier Proteins/metabolism , Drug Resistance, Microbial/genetics , Drug Resistance, Multiple, Bacterial/drug effects , Humans , Microbial Sensitivity Tests
2.
Complement Ther Med ; 45: 254-261, 2019 Aug.
Article in English | MEDLINE | ID: mdl-31331571

ABSTRACT

PURPOSE: The objective of the present study was to evaluate the systemic anti-inflammatory activity of the hydroalcoholic extract of the leaves of Licania rigida Benth (EHFLR) on models of systemic inflammation in mice. METHODS: The quantitative chemical profiles of phenolic acids and flavonoids were performed by High-Performance Liquid Chromatography (HPLC). Systemic anti-inflammatory activity was determined from carrageenan and dextran-induced paw edema models and the animals were orally treated (p.o.) with EHFLR at doses of 25, 50, 100 mg/kg, indomethacin (10 mg/kg) for carrageenan-induced paw edema and promethazine (6 mg/kg) for dextran-induced paw edema. The possible mechanisms involved in the anti-inflammatory action of the extract were evaluated by the paw edema models induced by histamine and arachidonic acid, and by the model of carrageenan-induced peritonitis, where vascular permeability and leukocyte migration to the peritoneal cavity were evaluated. RESULTS: The results of the HPLC identified the presence of phenolic acids and flavonoids, with chlorogenic acid (1.16%) and Caempferol (0.81%) as the main constituents. From the results, it was concluded that the extract has an LD50 ≥5000 mg/kg when administered orally in mice as this dose did not trigger deaths in any of the observed groups. EHFLR (25 mg/kg) showed a significant antiderematogenic effect on histamine and arachidonic acid-induced paw edema at the third hour of the tests, with a percentage of inhibition of 46.64% and 18.33%, respectively. The extract (25 mg/kg, p.o.) also significantly reduced vascular permeability and leukocyte migration in the peritoneal cavity. CONCLUSIONS: It is concluded that EHFLR exerts a systemic anti-inflammatory action, which seems to depend, at least in part, on the inhibition of arachidonic acid metabolism and the action of vasoactive amines. In addition, the extract reduced the leukocyte migration in the peritoneal cavity, indicating that its action may be linked to the inhibition of pro-inflammatory cytokines.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Chrysobalanaceae/chemistry , Inflammation/chemically induced , Inflammation/drug therapy , Plant Extracts/pharmacology , Animals , Carrageenan/pharmacology , Edema/chemically induced , Edema/drug therapy , Flavonoids/pharmacology , Hydroxybenzoates/pharmacology , Male , Mice , Peritonitis/chemically induced , Peritonitis/drug therapy , Phytotherapy/methods , Plant Leaves/chemistry
3.
Phytother Res ; 31(11): 1747-1756, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28840616

ABSTRACT

Orange jasmine, Murraya paniculata (Rutaceae), is a plant from India widely used in folk medicine as antinociceptive, antiinflammatory, and antioxidant. Although oral hypoglycemic agents and insulin are the mainstays of treatment of diabetes mellitus (DM), there is a significant demand for new natural products to reduce the development of diabetic complications. Alloxan-induced diabetic rats were treated for 60 days with a hydroalcoholic extract of M. paniculata (MPE), at doses of 100, 200, and 400 mg/kg. MPE decreased glycemia and also cholesterol and triglyceride levels, starting 1 week after treatments, as compared with the same group before treatments. Glucose values were reduced toward normality after 1 week of treatment. MPE hypoglycemic effects were potentiated by glibenclamide and metformin. MPE also decreased fructosamine and glycated hemoglobin values. MPE reduced diabetes-induced morphological alterations of the kidney, pancreas, and liver. MPE acts similarly to glibenclamide and metformin, and its glucose-lowering action is partly a consequence of ATP-sensitive K+ channel inhibition. MPE may be a potential therapeutic alternative for the treatment of diabetes and its complications. Copyright © 2017 John Wiley & Sons, Ltd.


Subject(s)
Diabetes Mellitus, Experimental/drug therapy , Dietary Supplements , Hypoglycemic Agents/pharmacology , Murraya/chemistry , Plant Extracts/pharmacology , Alloxan , Animals , Blood Glucose/drug effects , Cholesterol/blood , Diabetes Mellitus, Experimental/chemically induced , Glyburide/pharmacology , India , Liver/drug effects , Male , Medicine, Traditional , Metformin/pharmacology , Pancreas/drug effects , Rats , Rats, Wistar , Triglycerides/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...